Success payments
Collaborative Arrangement, Rights And Obligations, Aggregate Success Payments
Collaborative Arrangement, Rights And Obligations, Aggregate Success Payments
Asset acquisition, contingent consideration, possible achievement, issuance of common shares
Asset Acquisition, Contingent Consideration, Possible Achieved, Issuance of Common Shares
Asset Acquisition, Contingent Consideration, Possible Achieved, Issuance of Common Shares
Statistical Measurement [Domain]
Statistical Measurement [Domain]
TD Securities (USA) LLC
TD Securities (USA) LLC [Member]
TD Securities (USA) LLC
Schedule of Fair Value and Amortized Cost of Marketable Securities
Debt Securities, Available-for-Sale [Table Text Block]
Award Timing Predetermined
Award Timing Predetermined [Flag]
2026 (remaining nine months)
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Entity File Number
Entity File Number
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Tabular List, Table
Tabular List [Table Text Block]
Leases [Abstract]
Leases [Abstract]
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Schedule of Operating Income From Sonoma and Income Attributable to Sonoma Sublease
Schedule of Related Party Transactions [Table Text Block]
Accounts payable
Increase (Decrease) in Accounts Payable
Interest income, net
Interest Income (Expense), Nonoperating
Gross Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Trading Arrangements, by Individual
Trading Arrangements, by Individual [Table]
Net loss per common share, basic (in dollars per share)
Earnings Per Share, Basic
Adjustment to Compensation:
Adjustment to Compensation [Axis]
Related-Party Transactions
Related Party Transactions Disclosure [Text Block]
Named Executive Officers, Footnote
Named Executive Officers, Footnote [Text Block]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Financial liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Shares available for issuance of common shares (in shares)
Common Stock, Capital Shares Reserved for Future Issuance
Schedule of Aggregate Potential Success Payments
Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]
Schedule of Stock by Class [Table]
Stock, Class of Stock [Table]
Schedule of Reporting Segment Financial Information
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Issuance of common stock in connection with restricted stock units, net of tax (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Schedule of Fair Value and Amortized Cost of Cash Equivalents
Cash, Cash Equivalent, and Investment [Table Text Block]
Success payment liabilities
Success Payment Liabilities, Fair Value Disclosure
Success Payment Liabilities, Fair Value Disclosure
Measurement Input Type [Domain]
Measurement Input Type [Domain]
Adjustment to Compensation, Amount
Adjustment to Compensation Amount
Asset acquisition, clinical milestone, contingent cash payment
Asset Acquisition, Clinical Milestone, Contingent Cash Payment
Asset Acquisition, Clinical Milestone, Contingent Cash Payment
Consolidations
Consolidation, Policy [Policy Text Block]
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Cumulative impairments of strategic investments
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
Stock option
Share-Based Payment Arrangement, Option [Member]
Award Timing MNPI Disclosure
Award Timing MNPI Disclosure [Text Block]
Term of success payment agreement
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Term
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Term
Total stockholders’ equity
Beginning balance
Ending balance
Equity, Attributable to Parent
Other comprehensive loss:
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Insider Trading Policies and Procedures [Line Items]
Stock-based compensation expense
Total stock-based compensation expense
Share-Based Payment Arrangement, Expense
Common stock authorized (in shares)
Common Stock, Shares Authorized
Equity Multiple [Domain]
Equity Multiple [Domain]
Equity Multiple Domain.
Issuance of common stock in connection with ATM financing (in shares)
Stock Issued During Period, Shares, New Issues
Current assets:
Assets, Current [Abstract]
Total liabilities and stockholders’ equity
Liabilities and Equity
Equity Multiple [Axis]
Equity Multiple [Axis]
Equity Multiple Axis.
Number of Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Award performance period (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period
Thirty Times
Thirty Times [Member]
Thirty Times (30x).
Concentrations of Credit Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities and Equity [Abstract]
Cover [Abstract]
Cover [Abstract]
Money market funds
Cash and Cash Equivalents, Fair Value Disclosure
Maximum
Maximum [Member]
Exercisable (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
General and administrative
General and Administrative Expense [Member]
Capital expenditures
Segment, Expenditure, Addition to Long-Lived Assets
Number of other investments fully impaired
Equity Securities without Readily Determinable Fair Value, Full Impairment, Number of Investments
Equity Securities without Readily Determinable Fair Value, Full Impairment, Number of Investments
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc [Member]
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc
Accounting Policies [Abstract]
Accounting Policies [Abstract]
Schedule of Future Minimum Operating Lease Commitments, Including Expected Lease Incentives to be Received
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Asset Acquisitions and Contingent Consideration
Asset Acquisition [Text Block]
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Total Compensation Amount
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Loss on property and equipment disposals, net
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Off-balance Sheet Risk
Off-Balance-Sheet Credit Exposure, Policy [Policy Text Block]
Adjustment to Non-PEO NEO Compensation Footnote
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Pay vs Performance Disclosure [Line Items]
Total operating lease liabilities
Total
Operating Lease, Liability
U.S. government agency securities
U.S. government agency securities
US Government Agencies Debt Securities [Member]
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Total financial liabilities
Financial Liabilities Fair Value Disclosure
Entity Shell Company
Entity Shell Company
Increase in prepaid clinical supply
Increase (Decrease) in Prepaid Supplies
Stock Options and Performance-Based Stock Options
Share-Based Payment Arrangement, Option And Performance-Based Stock Options [Member]
Share-Based Payment Arrangement, Option And Performance-Based Stock Options
Other non-current liabilities
Other Liabilities, Noncurrent
Statement of Stockholders' Equity [Abstract]
Statement of Stockholders' Equity [Abstract]
Schedule of PSU Activity
Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
Statement of Cash Flows [Abstract]
Statement of Cash Flows [Abstract]
Company Selected Measure Amount
Company Selected Measure Amount
2029
Lessee, Operating Lease, Liability, to be Paid, Year Three
Award Timing MNPI Considered
Award Timing MNPI Considered [Flag]
Other non-current liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Measurement Input Type [Axis]
Measurement Input Type [Axis]
Name
Measure Name
Marketable securities, non-current
Marketable Securities, Noncurrent [Member]
Marketable Securities, Noncurrent
Schedule of Stock-based Compensation Expense by Classification
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Short-term portion of lease liabilities (included in accrued liabilities and other current liabilities)
Operating Lease, Liability, Current
Asset acquisition, contingent consideration arrangements, entity shares issuable (in shares)
Asset Acquisition, Contingent Consideration, Equity Interests Issued and Issuable, Entity Shares Issuable
Asset Acquisition, Contingent Consideration, Equity Interests Issued and Issuable, Entity Shares Issuable
Schedule of Changes in the Estimated Fair Value of Level 3 Financial Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Class of Stock [Line Items]
Class of Stock [Line Items]
Document Fiscal Period Focus
Document Fiscal Period Focus
Other operating income, net - subleases
Sublease Income, Other Operating Income, Net
Sublease Income, Other Operating Income, Net
Cash paid for amounts included in the measurement of lease liabilities
Cash Paid For Amounts Included In Measurement Of Lease Liabilities
Cash paid for amounts included in the measurement of lease liabilities.
Award Timing Method
Award Timing Method [Text Block]
Award Type [Axis]
Award Type [Axis]
Total assets
Assets
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Investment, Name [Domain]
Investment, Name [Domain]
Trading Symbol
Trading Symbol
2030
Lessee, Operating Lease, Liability, to be Paid, Year Four
PSUs vested (in dollars per share)
RSUs vested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Geographical [Domain]
Geographical [Domain]
Accrued liabilities and other current liabilities
Accrued Liabilities and Other Liabilities
Proportion of stock outstanding (as a percent)
Share-Based Compensation Arrangement By Share-based Payment Award, Additional Shares Authorized, Number Of Shares As Percentage Of Common Shares Outstanding
Share-Based Compensation Arrangement By Share-based Payment Award, Additional Shares Authorized, Number Of Shares As Percentage Of Common Shares Outstanding
Entity Address City Or Town
Entity Address, City or Town
CASH FLOWS FROM OPERATING ACTIVITIES
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Summary of Significant Accounting Policies
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
Marketable Securities [Line Items]
Marketable Securities [Line Items]
Other segment items
Segment Reporting, Other Segment Item, Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Income Statement Location [Domain]
Statement of Income Location, Balance [Domain]
RSUs
Restricted Stock Units (RSUs) [Member]
Service period from the milestone achievement date
Share-Based Compensation Arrangement by Share-Based Payment Award, Service Period from Milestone Achievement Date
Share-Based Compensation Arrangement by Share-Based Payment Award, Service Period from Milestone Achievement Date
Compensation Actually Paid vs. Other Measure
Compensation Actually Paid vs. Other Measure [Text Block]
Financial assets:
Assets, Fair Value Disclosure [Abstract]
Entity Emerging Growth Company
Entity Emerging Growth Company
Other investments
Other Investments
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Beginning balance (in shares)
Ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]
Level 2
Fair Value, Inputs, Level 2 [Member]
Insider Trading Policies and Procedures Not Adopted
Insider Trading Policies and Procedures Not Adopted [Text Block]
Related Party
Related Party [Member]
Common stock outstanding (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Outstanding
Plan Name [Axis]
Plan Name [Axis]
PEO
PEO [Member]
Non-cash investing and financing activities:
Noncash Investing and Financing Items [Abstract]
Awards issued during period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Issuance of common stock upon exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Accumulated Deficit
Retained Earnings [Member]
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Performance-Based Restricted Stock Units Outstanding
Restricted Stock Units Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Entity Address Postal Zip Code
Entity Address, Postal Zip Code
Restatement Determination Date
Restatement Determination Date
Potential aggregate success payments
Aggregate success payment(s) (in millions)
Collaborative Arrangement, Rights And Obligations, Aggregate Potential Success Payments
Collaborative Arrangement, Rights And Obligations, Aggregate Potential Success Payments
Multiple of initial equity value at issuance
Collaborative Arrangement, Rights And Obligations, Potential Payment Multiplier
Collaborative Arrangement, Rights And Obligations, Potential Payment Multiplier
Share-based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Total
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Fair value of securities held in a continuous unrealized loss position for greater than twelve months
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer
Sale of Stock [Domain]
Sale of Stock [Domain]
Preferred stock issued (in shares)
Preferred Stock, Shares Issued
Pension Adjustments Service Cost
Pension Adjustments Service Cost [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Forty Times
Forty Times [Member]
Forty Times (40x).
Restatement does not require Recovery
Restatement Does Not Require Recovery [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
City Area Code
City Area Code
Award Timing, How MNPI Considered
Award Timing, How MNPI Considered [Text Block]
All Trading Arrangements
All Trading Arrangements [Member]
Equity Awards Adjustments, Footnote
Equity Awards Adjustments, Footnote [Text Block]
Total Shareholder Return Vs Peer Group
Total Shareholder Return Vs Peer Group [Text Block]
Settlement via equity issuance
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Balance at beginning of period (in shares)
Balance at end of period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
CASH FLOWS FROM INVESTING ACTIVITIES
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
General and administrative
General and Administrative Expense
Pay vs Performance Disclosure
Pay vs Performance Disclosure [Table]
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Related Party Transactions [Abstract]
Related Party Transactions [Abstract]
Preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Schedule of Assumptions Used in Black-Scholes Option-Pricing Model for Estimating Fair Value of Stock Options Granted
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Lease costs
Lease, Cost
Equity Valuation Assumption Difference, Footnote
Equity Valuation Assumption Difference, Footnote [Text Block]
Schedule of Total Income Attributable to Sublease
Lease, Cost [Table Text Block]
PEO Total Compensation Amount
PEO Total Compensation Amount
Money market funds
Money market funds
Money Market Funds [Member]
Technical operations
Technical Operations Expense
Technical Operations Expense
Equity Components [Axis]
Equity Components [Axis]
Sublease income
Sonoma sublease income
Sublease Income
Non-Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Number of reportable segments
Number of Reportable Segments
Variable interest entity, number of entities company is not primary beneficiary
Variable Interest Entity, Number of Investments that Company is Not the Primary Beneficiary
Variable Interest Entity, Number of Investments that Company is Not the Primary Beneficiary
SUPPLEMENTAL CASH FLOW INFORMATION
Supplemental Cash Flow Information [Abstract]
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost
Other Performance Measure, Amount
Other Performance Measure, Amount
Weighted- Average Exercise Price Per Share
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Per share common stock price required for payment (in dollars per share)
Collaborative Arrangement, Rights And Obligations, Aggregate Potential Success Payments, Share Price
Collaborative Arrangement, Rights And Obligations, Aggregate Potential Success Payments, Share Price
Entity Address State Or Province
Entity Address, State or Province
Related Party [Domain]
Related and Nonrelated Parties [Domain]
Total current liabilities
Liabilities, Current
Trigger period thereafter
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Trigger Period After Initial Public Offering
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Trigger Period Thereafter
Individual:
Individual [Axis]
Vesting [Axis]
Vesting [Axis]
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock
Research and development
Research and Development Expense [Member]
Net cash provided by investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]
Document Fiscal Year Focus
Document Fiscal Year Focus
Variable interest entity maximum loss exposure, amount
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Forgone Recovery, Explanation of Impracticability
Forgone Recovery, Explanation of Impracticability [Text Block]
Entity Interactive Data Current
Entity Interactive Data Current
Operating lease cost
Operating Lease, Cost
Plan Name [Domain]
Plan Name [Domain]
Expected weighted-average period for compensation cost to be recognized
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Asset acquisition, commercial sales milestones, maximum contingent cash payment
Asset Acquisition, Commercial Sales Milestones, Maximum Contingent Cash Payment
Asset Acquisition, Commercial Sales Milestones, Maximum Contingent Cash Payment
Issuance of common stock upon exercise of stock options (in shares)
Exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Equity [Abstract]
Equity [Abstract]
Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Segment
Segment Reporting Disclosure [Text Block]
At The Market Offering
At The Market Offering [Member]
At The Market Offering
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
U.S. Treasury securities
U.S. Treasury securities
US Treasury Securities [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in fair value of contingent consideration payable
Asset Acquisition, Contingent Consideration Arrangements, Change in Fair Value
Asset Acquisition, Contingent Consideration Arrangements, Change in Fair Value
Marketable securities, non-current
Marketable Securities, Noncurrent
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Recurring and Nonrecurring [Table]
Research activities
Research Activities Expense
Research Activities Expense
Volatility
Measurement Input, Price Volatility [Member]
Depreciation and amortization expense
Depreciation, Depletion and Amortization
Other non-current assets
Other Assets, Noncurrent
Entity Central Index Key
Entity Central Index Key
Awards granted, percentage of target
Share-Based Compensation Arrangement by Share-Based Payment Award, Awards Granted, Percentage of Target
Share-Based Compensation Arrangement by Share-Based Payment Award, Awards Granted, Percentage of Target
PEO Name
PEO Name
Revenue
Revenues
Proceeds from sale of stock
Sale of Stock, Consideration Received on Transaction
SPA put/call
Financial Liability, Securities Purchase Agreement, Fair Value Disclosure
Financial Liability, Securities Purchase Agreement, Fair Value Disclosure
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]
Outstanding Aggregate Erroneous Compensation Amount
Outstanding Aggregate Erroneous Compensation Amount
Beginning balance
Ending balance
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
ICT License Acquisition
ICT License Acquisition [Member]
ICT License Acquisition
Arrangement Duration
Trading Arrangement Duration
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Achievement of applicable milestone
Share-Based Payment Arrangement, Tranche One [Member]
Segments [Axis]
Segments [Axis]
Prepaid expenses, other current assets and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Exercise Price
Award Exercise Price
Fair Value by Liability Class [Domain]
Fair Value by Liability Class [Domain]
Prepaid clinical supply cap
Asset Acquisition, Prepaid Clinical Supply, Maximum Amount
Asset Acquisition, Prepaid Clinical Supply, Maximum Amount
Entity Filer Category
Entity Filer Category
Class of Stock [Domain]
Class of Stock [Domain]
Local Phone Number
Local Phone Number
Additional 402(v) Disclosure
Additional 402(v) Disclosure [Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Closing price of stock (in dollars per share)
Share Price
Stock-based Compensation
Share-Based Payment Arrangement [Text Block]
ASSETS
Assets [Abstract]
Underlying Security Market Price Change
Underlying Security Market Price Change, Percent
Balance Sheet Location [Axis]
Statement of Financial Position Location, Balance [Axis]
Vesting [Domain]
Vesting [Domain]
PSUs forfeited or canceled (in dollars per share)
RSUs forfeited or canceled (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Fair Value Measurements
Fair Value Disclosures [Text Block]
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]
Award vesting rights, percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Entity Address Line
Entity Address, Address Line One
Sale of stock, maximum aggregate offering amount
Sale of Stock, Maximum Consideration Received
Sale of Stock, Maximum Consideration Received
Non-cash lease income
Non-Cash Lease Income (Expense)
Non-Cash Lease Income (Expense)
Research and development
Research and Development Expense
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent [Member]
Investment, Name [Axis]
Investment, Name [Axis]
Accrued liabilities and other current liabilities
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Operating lease liabilities, non-current
Operating lease liabilities, non-current
Operating Lease, Liability, Noncurrent
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
Support functions
Support Functions Expense
Support Functions Expense
Fair Value as of Grant Date
Award Grant Date Fair Value
Entity Registrant Name
Entity Registrant Name
Stock Price or TSR Estimation Method
Stock Price or TSR Estimation Method [Text Block]
Aggregate Intrinsic Value (in thousands)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]
Issuance of common stock in connection with PIPE financing
Stock Issued During Period, Value, PIPE Financing
Stock Issued During Period, Value, PIPE Financing
PSUs granted (in shares)
RSUs granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
PSUs forfeited or canceled (in shares)
RSUs forfeited or canceled (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Stock-based compensation cost related to unvested awards not yet recognized
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Document Quarterly Report
Document Quarterly Report
Fair value of securities held in a continuous unrealized loss position for less than twelve months
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months
Total financial assets
Assets, Fair Value Disclosure
Change in fair value of success payment liabilities
Fair Value Adjustment Of Success Payment Liabilities
Fair value adjustment of success payment liabilities
Schedule of Assumptions Used to Value Level 3 Financial Instruments
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Changed Peer Group, Footnote
Changed Peer Group, Footnote [Text Block]
Counterparty Name [Domain]
Counterparty Name [Domain]
Asset acquisition, late-stage regulatory milestone, maximum contingent cash payment
Asset Acquisition, Late-Stage Regulatory Milestone, Maximum Contingent Cash Payment
Asset Acquisition, Late-Stage Regulatory Milestone, Maximum Contingent Cash Payment
2028
Lessee, Operating Lease, Liability, to be Paid, Year Two
Investments, All Other Investments [Abstract]
Reverse stock split
Stockholders' Equity Note, Stock Split, Conversion Ratio
Net amortization and accretion on marketable securities
Accretion (Amortization) of Discounts and Premiums, Investments
Adjustment To PEO Compensation, Footnote
Adjustment To PEO Compensation, Footnote [Text Block]
Options outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
PSUs granted (in dollars per share)
RSUs granted (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Related Party [Axis]
Related and Nonrelated Parties [Axis]
Title
Trading Arrangement, Individual Title
Peer Group Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Operations management
Operations Management Expense
Operations Management Expense
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Restatement Determination Date:
Restatement Determination Date [Axis]
Non-PEO NEO
Non-PEO NEO [Member]
Options outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Sale of Stock [Axis]
Sale of Stock [Axis]
Gross Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Name
Trading Arrangement, Individual Name
Award Type [Domain]
Award Type [Domain]
2027
Lessee, Operating Lease, Liability, to be Paid, Year One
Equity Awards Adjustments
Equity Awards Adjustments [Member]
Pension Benefits Adjustments, Footnote
Pension Benefits Adjustments, Footnote [Text Block]
Compensation Amount
Outstanding Recovery Compensation Amount
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Statement of Comprehensive Income [Abstract]
Statement of Comprehensive Income [Abstract]
Recovery of Erroneously Awarded Compensation Disclosure [Line Items]
Schedule of Investments [Line Items]
Schedule of Investments [Line Items]
Equity issued for contingent consideration
Asset Acquisition, Contingent Consideration, Equity Issuance
Asset Acquisition, Contingent Consideration, Equity Issuance
MNPI Disclosure Timed for Compensation Value
MNPI Disclosure Timed for Compensation Value [Flag]
Name
Awards Close in Time to MNPI Disclosures, Individual Name
Balance at beginning of period (in dollars per share)
Balance at end of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Restricted cash
Restricted cash
Restricted Cash, Noncurrent
Thereafter
Lessee, Operating Lease, Liability, To Be Paid, After Year Four
Lessee, Operating Lease, Liability, To Be Paid, After Year Four
Aggregate Erroneous Compensation Not Yet Determined
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Asset Acquisition [Line Items]
Asset Acquisition [Line Items]
Beneficial ownership of investor after transaction (as a percent)
Sale of Stock, Beneficial Ownership of Investor After Transaction
Sale of Stock, Beneficial Ownership of Investor After Transaction
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Accumulated other comprehensive (loss) income
Accumulated Other Comprehensive Income (Loss), Net of Tax
Classified as:
Cash Equivalents And Debt Securities, Available-For-Sale [Abstract]
Cash Equivalents And Debt Securities, Available-For-Sale
Significant Accounting Policies
Significant Accounting Policies [Policy Text Block]
Significant Accounting Policies
Financial Instruments [Domain]
Financial Instruments [Domain]
Liability Class [Axis]
Liability Class [Axis]
Segments [Domain]
Segments [Domain]
Asset acquisition, upfront cash payment
Asset Acquisition, Upfront Cash Payment
Asset Acquisition, Upfront Cash Payment
Income Statement Location [Axis]
Statement of Income Location, Balance [Axis]
PSUs
Performance Shares [Member]
South San Francisco, California
South San Francisco, California [Member]
South San Francisco, California
Aggregate Pension Adjustments Service Cost
Aggregate Pension Adjustments Service Cost [Member]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Balance Sheet Location [Domain]
Statement of Financial Position Location, Balance [Domain]
Minimum
Minimum [Member]
Fifty Times
Fifty Times [Member]
Fifty Times (50x).
Company Selected Measure Name
Company Selected Measure Name
Clinical development
Clinical Development Expense
Clinical Development Expense
Purchases of marketable securities
Payments to Acquire Debt Securities, Available-for-Sale
Preferred stock, $0.0001 par value; 10,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025
Preferred Stock, Value, Issued
Aggregate Available
Trading Arrangement, Securities Aggregate Available Amount
Accounts payable
Accounts Payable, Current
Stock Appreciation Rights (SARs)
Stock Appreciation Rights (SARs) [Member]
All Executive Categories
All Executive Categories [Member]
Common stock, value, issued
Common Stock, Value, Issued
Success payment liability
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Liability
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Liability
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Earlier of one year of service from achievement date and three-year performance period
Share-Based Payment Arrangement, Tranche Two [Member]
Weighted-average shares used to compute net loss per common share, diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Commitments and contingencies (Note 12)
Commitments and Contingencies
Non-GAAP Measure Description
Non-GAAP Measure Description [Text Block]
Entity Small Business
Entity Small Business
Asset acquisition, upfront payment
Payments for Asset Acquisitions, Net of Cash Acquired
Payments for Asset Acquisitions, Net of Cash Acquired
Preferred stock outstanding (in shares)
Preferred Stock, Shares Outstanding
Success payment liability
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Fair Value Of Liability
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Fair Value Of Liability
Document Transition Report
Document Transition Report
Rentable area (in square feet)
Net Rentable Area
Underlying Securities
Award Underlying Securities Amount
Equity Component [Domain]
Equity Component [Domain]
Document Period End Date
Document Period End Date
PEO Actually Paid Compensation Amount
PEO Actually Paid Compensation Amount
Cash and Cash Equivalents [Domain]
Cash and Cash Equivalents [Domain]
Canceled or forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Stanford
Stanford [Member]
Stanford.
Cash Equivalents and Marketable Securities
Cash, Cash Equivalent, and Marketable Security [Text Block]
Trigger period from IPO date
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Trigger Period From Initial Public Offering Date
Collaborative Arrangement, Rights And Obligations, Success Payment Agreement, Trigger Period From Initial Public Offering Date
2021 Plan
Two Thousand Twenty One Equity Incentive Plan [Member]
Two thousand twenty one equity incentive plan.
Awards Close in Time to MNPI Disclosures, Table
Awards Close in Time to MNPI Disclosures [Table Text Block]
Schedule of Investments [Table]
Schedule of Investments [Table]
Asset acquisition, contingent consideration probable achievement, share-based compensation expense
Asset Acquisition, Contingent Consideration, Probable Achievement, Share-Based Compensation Expense
Asset Acquisition, Contingent Consideration, Probable Achievement, Share-Based Compensation Expense
Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Asset acquisition, tiered royalties, annual net sales, maximum percentage
Asset Acquisition, Tiered Royalties, Annual Net Sales, Maximum Percentage
Asset Acquisition, Tiered Royalties, Annual Net Sales, Maximum Percentage
Asset acquisition, share issuance (in shares)
Asset Acquisition, Share Issuance
Asset Acquisition, Share Issuance
Document Type
Document Type
Level 3
Fair Value, Inputs, Level 3 [Member]
Net Loss Per Share
Earnings Per Share [Text Block]
Name
Outstanding Recovery, Individual Name
Marketable Securities [Table]
Marketable Securities [Table]
Additional paid-in capital
Additional Paid in Capital
Asset Acquisition [Domain]
Asset Acquisition [Domain]
Proceeds from equity issuance/offering
Proceeds from equity financing
Proceeds from Issuance of Common Stock
Variable lease cost
Variable Lease, Cost
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]
All Individuals
All Individuals [Member]
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Abstract]
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Name
Forgone Recovery, Individual Name
Award expiration period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Total current assets
Assets, Current
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]
Cancelled or forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Sonoma
Sonoma [Member]
Sonoma
Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Amount
Employee purchase of shares, proportion of fair value (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Taxes paid related to net share settlement of equity awards
Payment, Tax Withholding, Share-Based Payment Arrangement
Securities Purchase Agreement
Securities Purchase Agreement
SPA Put/Call (Asset) Liability
Securities Purchase Agreement [Member]
Securities Purchase Agreement
Peer Group Issuers, Footnote
Peer Group Issuers, Footnote [Text Block]
Marketable securities
Marketable Securities, Current
Erroneous Compensation Analysis
Erroneous Compensation Analysis [Text Block]
Maturity of marketable securities (in years)
Debt Securities, Available-for-Sale, Term
Commissions payment, percentage of gross sale proceeds
Sale of Stock, Commissions Payment, Percentage of Gross Sale Proceeds
Sale of Stock, Commissions Payment, Percentage of Gross Sale Proceeds
Marketable securities
Marketable Securities, Current [Member]
Marketable Securities, Current
Other comprehensive loss
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Current liabilities:
Liabilities, Current [Abstract]
Weighted- Average Remaining Contractual Life (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Geographical [Axis]
Geographical [Axis]
Lessee, Lease, Description [Line Items]
Lessee, Lease, Description [Line Items]
Total operating expenses
Operating Expenses
Rule 10b5-1 Arrangement Terminated
Rule 10b5-1 Arrangement Terminated [Flag]
Level 1
Fair Value, Inputs, Level 1 [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Leases
Lessor, Operating Leases [Text Block]
Schedule of Related Party Transactions, by Related Party [Table]
Related Party Transaction [Table]
Net loss per common share, diluted (in dollars per share)
Earnings Per Share, Diluted
Erroneously Awarded Compensation Recovery
Erroneously Awarded Compensation Recovery [Table]
Title12(b) Security
Title of 12(b) Security
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Table]
Success payment expense reversals
Collaborative Arrangement, Rights And Obligations, Success Payment Expense (Gain)
Collaborative Arrangement, Rights And Obligations, Success Payment Expense (Gain)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Sale of stock, sold and issued (in shares)
Sale of Stock, Number of Shares Issued in Transaction
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Fred Hutch
Fred Hutch [Member]
Fred Hutch
Total other income, net
Nonoperating Income (Expense)
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity, Not Primary Beneficiary [Member]
Milestone Closing
Milestone Closing [Member]
Milestone Closing
Asset Acquisition [Table]
Asset Acquisition [Table]
Less: imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Exercised (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Cash equivalents
Cash Equivalents [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Award Timing Disclosures [Line Items]
Granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Total undiscounted lease payments
Lessee, Operating Lease, Liability, to be Paid
Net unrealized loss on marketable securities
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Stockholders’ Equity
Equity [Text Block]
Stock issued during period, shares, acquisitions (in shares)
Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Shares
Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Shares
Net loss
Net loss
Net loss
Net loss
Net Income (Loss) Attributable to Parent
Prepaid clinical supply
Prepaid Clinical Supply
Prepaid Clinical Supply
Expiration Date
Trading Arrangement Expiration Date
Operating Lease Liability
Operating Lease, Liability [Abstract]
Asset acquisition, clinical and regulatory milestones, maximum contingent share issuance
Asset Acquisition, Clinical and Regulatory Milestones, Maximum Contingent Share Issuance
Asset Acquisition, Clinical and Regulatory Milestones, Maximum Contingent Share Issuance
Stockholders’ equity:
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Loss on marketable equity security
Equity Securities, FV-NI, Unrealized Gain (Loss)
Vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Property and equipment, net
Property, Plant and Equipment, Net
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Preferred stock authorized (in shares)
Preferred Stock, Shares Authorized
Adoption Date
Trading Arrangement Adoption Date
Reclassification
Reclassification, Comparability Adjustment [Policy Text Block]
Represented by:
Represented By Cash And Cash Equivalents And Restricted Cash [Abstract]
Represented by Cash and Cash Equivalents and Restricted Cash.
Convertible preferred stock, par value (in dollars per share)
Shares Issued, Price Per Share
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income [Text Block]
Entity Current Reporting Status
Entity Current Reporting Status
Time to maturity (years)
Measurement Input, Expected Term [Member]
Awards Close in Time to MNPI Disclosures
Awards Close in Time to MNPI Disclosures [Table]
Loss from operations
Operating Income (Loss)
Consolidated Entities [Domain]
Consolidated Entities [Domain]
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Other Investment
Other Investment [Member]
Other Investment.
Success Payment Liabilities
Success Payment Liability [Member]
Success Payment Liability
Financial Instrument [Axis]
Financial Instrument [Axis]
Statement of Financial Position [Abstract]
Statement of Financial Position [Abstract]
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]
Executive Category:
Executive Category [Axis]
Other operating income, net
Other operating income, net - subleases
Other Operating Income (Expense), Net
Class of Stock [Axis]
Class of Stock [Axis]
Current Fiscal Year End Date
Current Fiscal Year End Date
Expected term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]
Weighted-Average Value at Grant Date Per Share
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Statement [Table]
Statement [Table]
Other income, net
Other Nonoperating Income (Expense)
Purchase of common stock at discount (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
License, Collaboration and Success Payment Agreements
Collaborative Arrangement Disclosure [Text Block]
CASH FLOWS FROM FINANCING ACTIVITIES
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Weighted average grant date fair value (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Equity Awards Adjustments, Excluding Value Reported in Compensation Table
Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]
PBOs
Performance-Based Stock Options [Member]
Performance-Based Stock Options
Risk-free rate
Measurement Input, Risk Free Interest Rate [Member]
Other Investments
Other Investments [Text Block]
The entire disclosure for other investments.
Clinical development milestones, probable achievement (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Clinical Development Milestones, Probable Achievement, Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Clinical Development Milestones, Probable Achievement, Shares
Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Organization
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Cash and Cash Equivalents [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
All Adjustments to Compensation
All Adjustments to Compensation [Member]
Amendment Flag
Amendment Flag
Sale of stock, price per share (in dollars per share)
Sale of Stock, Price Per Share
Leases
Lessee, Operating Leases [Text Block]
Termination Date
Trading Arrangement Termination Date
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Adopted [Flag]
Measure:
Measure [Axis]
Operating lease, weighted average discount rate (as a percent)
Operating Lease, Weighted Average Discount Rate, Percent
Schedule of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Issuance of common stock in connection with restricted stock units, net of tax
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Weighted-average shares used to compute net loss per common share, basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Exercisable (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Subsequent Events [Abstract]
Subsequent Events [Abstract]
Segment Reporting [Abstract]
Reportable segment
Reportable segment [Member]
Reportable segment
Pay vs Performance Disclosure, Table
Pay vs Performance [Table Text Block]
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Schedule of RSU Activity
Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]
Entity Tax Identification Number
Entity Tax Identification Number
Performance period relative to total shareholder return (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Performance Period Relative to Total Shareholder Return
Share-Based Compensation Arrangement by Share-Based Payment Award, Performance Period Relative to Total Shareholder Return
Ten Times
Ten Times [Member]
Ten Times (10x).
Securities purchase agreement, measurement input
Financial Liability, Securities Purchase Agreement, Measurement Input
Financial Liability, Securities Purchase Agreement, Measurement Input
Asset Acquisition [Axis]
Asset Acquisition [Axis]
Beginning balance (in dollars per share)
Ending balance (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Expense of Enforcement, Amount
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Consolidated Entities [Axis]
Consolidated Entities [Axis]
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock issued (in shares)
Common Stock, Shares, Issued
Weighted average remaining lease term of operating leases (in years)
Operating Lease, Weighted Average Remaining Lease Term
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Gain on securities purchase agreement put/call
Gain (Loss) on Financial Instrument, Securities Purchase Agreement
Gain (Loss) on Financial Instrument, Securities Purchase Agreement
2021 ESPP
Two Thousand Twenty One Employee Stock Purchase Plan [Member]
Two thousand twenty one employee stock purchase plan.
Schedule of Current and Non-current Lease Liabilities
Lessee, Current and Non-Current Liabilities [Table Text Block]
Lessee, Current and Non-Current Liabilities
Trading Arrangement:
Trading Arrangement [Axis]
Total Shareholder Return Amount
Total Shareholder Return Amount
Change in fair value
Change in fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Subsequent Events
Subsequent Events [Text Block]
Insider Trading Arrangements [Line Items]
Security Exchange Name
Security Exchange Name
Tenant improvements
Tenant Improvements
Twenty Times
Twenty Times [Member]
Twenty Times (20x).
Total liabilities
Liabilities
Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents [Axis]
Purchases of property and equipment included in accounts payable and accrued liabilities
Capital Expenditures Incurred but Not yet Paid
Issuance of common stock in connection with PIPE financing (in shares)
Stock Issued During Period, Shares, PIPE Financing
Stock Issued During Period, Shares, PIPE Financing
Pension Adjustments Prior Service Cost
Pension Adjustments Prior Service Cost [Member]
Maturities of marketable securities
Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale
Operating expenses:
Operating Expenses [Abstract]
Material Terms of Trading Arrangement
Material Terms of Trading Arrangement [Text Block]
ImmPACT Bio USA Inc.
ImmPACT Bio USA Inc. [Member]
ImmPACT Bio USA Inc.
Issuance of common stock in connection with ATM financing
Stock Issued During Period, Value, New Issues
Statement [Line Items]
Statement [Line Items]
Taxes paid related to net share settlement of equity awards
Payment (Proceeds), Tax Withholding, Share-Based Payment Arrangement
Payment (Proceeds), Tax Withholding, Share-Based Payment Arrangement
Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Adopted [Flag]
Cash and cash equivalents
Cash and cash equivalents
Cash and Cash Equivalent
Counterparty Name [Axis]
Counterparty Name [Axis]
Number of additional shares authorized for issuance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized
Common Stock
Common Stock [Member]
PSUs vested (in shares)
RSUs vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Fair Value
Marketable securities
Debt Securities, Available-for-Sale
Entity Incorporation State Country Code
Entity Incorporation, State or Country Code
Non-NEOs
Non-NEOs [Member]
Corporate debt securities
Corporate debt securities
Corporate Debt Securities [Member]
Net increase in cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
ARCH Venture Fund XIII
ARCH Venture Fund XIII [Member]
ARCH Venture Fund XIII